Abstract
This chapter discusses Fabry–Anderson disease (FAD), which is an X-linked glycolipid lysosomal storage disorder that is caused by an alpha-galactosidase deficiency. The unusual array of mostly nonspecific symptoms by which FAD may express itself explains why these historical difficulties are still extant for the clinician who needs to distinguish a rare disorder under commonplace manifestations. FAD is a chronic malady with lifelong, mostly nonspecific manifestations. The first symptom of FAD is generally a bout of excruciating burning pain in the extremities. Clinical signs of peripheral neuropathy are not a feature of FAD. Because globoside, the major erythrocyte glycolipid, is an important source of ceramide trihexoside during the degradation of aging cells, one would expect that the reticuloendothelial system is heavily involved, as is the rule in the multisystemic storage disorders.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.